A mathematical model of prostate tumor growth under hormone therapy with mutation inhibitor

Journal of Nonlinear Science

Volumn 20, Issue 2, 2010, Pages 219-240

  Tao, Youshan ^a   Guo, Qian ^b   Aihara, Kazuyuki ^c  

^a DONGHUA UNIVERSITY   (China)

^b SHANGHAI NORMAL UNIVERSITY   (China)

^c INSTITUTE OF INDUSTRIAL SCIENCE   (Japan)

Author keywords

Free boundary problem; Hormone therapy; Inhibitors; Partial differential equations; Prostate cancer

Indexed keywords

ANDROGEN-DEPENDENT; EXPLICIT FORMULA; FREE BOUNDARY; FREE-BOUNDARY PROBLEMS; GLOBAL EXISTENCE AND UNIQUENESS; HORMONE THERAPY; JACKSON; MUTATION RATES; NEW MODEL; NUMERICAL SIMULATION; PARABOLIC EQUATIONS; PROLIFERATION AND APOPTOSIS; PROSTATE CANCERS; PROSTATE TUMOR; QUALITATIVE ANALYSIS; RADIAL SYMMETRYS; TUMOR CELLS; TUMOR GROWTH; TUMOR VOLUMES;

CELL DEATH; COMPUTATIONAL FLUID DYNAMICS; COMPUTER SIMULATION; NONLINEAR EQUATIONS; PARTIAL DIFFERENTIAL EQUATIONS; POPULATION STATISTICS; QUALITY CONTROL; TUMORS;

MATHEMATICAL MODELS;

EID: 77953325145     PISSN: 09388974     EISSN: 14321467     Source Type: Journal    
DOI: 10.1007/s00332-009-9056-z     Document Type: Article

References (38)

1. Ambrosi, D., Preziosi, L.: On the closure of mass balance models for tumor growth.Math. Models Methods Appl. Sci. 12, 737-754 (2002)
2. Bellomo, N., Delitala, M.: From the mathematical kinetic, and stochastic game theory to modelling mutations, onset, progression and immune competition of cancer cells. Phys. Life Rev. 5, 183-206 (2008)
3. Bellomo, N., Li, N.K., Maini, P.K.: On the foundations of cancer modelling: selected topics, speculations, and perspectives. Math. Models Methods Appl. Sci. 18, 593-646 (2008)
4. Bresch, D., Colin, T., Grenier, E., Ribba, B., Saut, O.: A viscoelastic model for avascular tumor growth, inria-00267292, Version 3, 1 Sep 2008. Preprint
5. Bruchovsky, N., Klotz, L., Crook, J., Malone, S., Ludgate, C., Morris, W.J., Gleave, M.E., Goldenberg, S.L.: Final results of the Canadian prospective phase II trial of intermittent androgen suppression for men in biochemical recurrence after radiotherapy for locally advanced prostate cancer. Cancer 107, 389-395 (2006)
6. Bruchovsky, N., Klotz, L., Crook, J., Larry, S., Goldenberg, S.L.: Locally advanced prostate cancer- biochemical results from a prospective phase II study of intermittent androgen suppression for men with evidence of psa relapse after radiotherapy. Cancer 109, 858-867 (2007) (Pubitemid 46333527)
7. Byrne, H.M., Chaplain, M.A.J.: Modelling the role of cell-cell adhesion in the growth and development of carcinoma. Math. Comput. Model. 12, 1-17 (1996)
8. Byrne, H.M., Alarcón, T.A., Murphy, J., Maini, P.K.: Modelling the response of vascular tumours to chemotherapy: a multiscale approach. Math. Models Methods Appl. Sci. 16, 1219-1241 (2006)
9. Carducci, M.A., Nelson, J.B., Chan-Tack, K.M., et al.: Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate. Clin. Cancer Res. 2, 379-387 (1996)
10. Chung, L.M.: The role of stromal-epithelial interaction in normal and malignant growth. Cancer Surv. 23, 33-42 (1995)
11. De Angelis, E., Jabin, P.E.: Qualitative analysis of a mean field model of tumor-immune system competition. Math. Models Methods Appl. Sci. 13, 187-206 (2003) (Pubitemid 36344999)
12. Ellis, W.J., Vessela, R.L., Buhler, K.R., Bladou, F., True, L.D., Bigler, S.A., Curtis, D., Lange, P.H.: Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCap 231. Clin. Cancer Res. 2, 1039-1048 (1996)
13. Ferlay, J., et al.: GLOBOCAN 2002: Cancer incidense, mortality and prevalence worldwide. IARC CnacerBase No. 5, Version 2.0. IARC Press, Lyon (2002)
14. Friedman, A.: Mathematical analysis and challenges arising from models of tumour growth. Math. Models Methods Appl. Sci. 17, 1751-1772 (2007)
15. Greenspan, H.: On the growth and stability of cell cultures and solid tumors. J. Theor. Biol. 56, 229-235 (1976)
16. Guo, Q., Tao, Y., Aihara, K.: Mathematical modelling of prostate tumor growth under intermittent androgen suppression with partial differential equations. Int. J. Bifur. Chaos 18, 3789-3797 (2008)
17. Holland, J.F., Frei, E.: Cancer Medicine, 5th edn. Harcourt Asia Pte Ltd., Singapore (2001)
18. Hsing, A., Tsao, L., Devesa, S.: International trends and patterns of prostate cancer incidence and mortality. Int. J. Cancer (Predat. Oncol.) 85, 60-67 (2000)
19. Ideta, A., Tanaka, G., Takeuchi, T., Aihara, K.: A mathematical model of intermittent androgen suppression for prostate cancer. J. Nonlinear Sci. 18, 593-614 (2008)
20. Isaacs, J.T., Coffey, D.S.: Adaptation versus selection as mechanism response for the relapse of prostatic cancer to androgen therapy as studied in the dunning R-3327-H adenocarcinoma. Cancer Res. 41, 5070-5075 (1981)
21. Jackson, T.L.: Vascular tumor growth and treatment: consequence of polyclonality, competition and dynamic vascular support. J. Math. Biol. 44, 201-226 (2002)
22. Jackson, T.L.: A mathematical model of prostate tumor growth and androgen-independent relapse. Discrete Contin. Dyn. Syst. B 4, 187-201 (2004a)
23. Jackson, T.L.: A mathematical investigation of multiple pathways to recurrent prostate cancer: comparison with experimental data. Neoplasia 6, 697-704 (2004b)
24. Jackson, T.L., Byrne, H.M.: A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumors to chemotherapy. Math. Biosci. 164, 17-38 (2000)
25. Kamradt, J.M., Pienta, K.J.: Novel molecular targets for prostate cancer therapy. Semin. Oncol. 26, 234-243 (1999)
26. Ladyzenskaja, O.A., Solonnikov, V.A., Ural'ceva, N.N.: Linear and Quasi-Linear Equations of Parabolic Type. Am. Math. Soc. Transl., vol.23. Am. Math. Soc., Providence (1968)
27. + cells of human prostate cancer xenograft LuCaP 23 following castration. Int. J. Cancer 65, 85-89 (1996)
28. Macri, E., Loda, M.: Role of p27 in prostate carcinogenesis. Cancer Metastasis Rev. 17, 337-344 (1998)
29. Ribba, B., Saut, O., Colin, T., Bresch, D., Grenier, E., Boissel, J.P.: A multiscale mathematical model of avascular tumor growth to investigate the therapeutic benefit of anti-invasive agents. J. Theor. Biol. 243, 532-541 (2006)
30. Shimada, T., Aihara, K.: A nonlinear model with competition between tumor cells and its application to intermittent androgen suppression therapy of prostate cancer. Math. Biosci. 214, 134-139 (2008)
31. Simon, C., Everitt, H., Birtwistle, J., Stevenson, B.: Oxford Handbook of General Practice. Oxford University Press, Oxford (2002)
32. Tao, Y.: A free boundary problem modeling the cell cycle and cell movement in multicellular tumor spheroids. J. Differ. Equ. 247, 49-68 (2009)
33. Tao, Y., Chen, M.: An elliptic-hyperbolic free boundary problem modelling cancer therapy. Nonlinearity 19, 419-440 (2006)
34. Tao, Y., Guo, Q.: A free boundary problem modelling cancer radiovirotherapy. Math. Models Methods Appl. Sci. 17, 1241-1259 (2007)
35. Tao, Y., Yoshida, N., Guo, Q.: Nonlinear analysis of a model of vascular tumour growth and treatment. Nonlinearity 17, 867-895 (2004)
36. Tao, Y., Guo, Q., Aihara, K.: A model at the macroscopic scale of prostate tumor growth under intermittent androgen suppression. Math. Models Methods Appl. Sci. (2009). doi:10.1142/S021820250900408X
37. Ward, J.P., King, J.R.: Mathematical modelling of drug transport in tumour multicell spheroids and monolayer cultures. Math. Biosci. 181, 177-207 (2003)
38. Ware, J.L.: Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer. Cancer Metastasis Rev. 12, 287-301 (1993)